REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $718,920 | -1.1% | 7,051 | -11.8% | 0.00% | -100.0% |
| Q1 2023 | $726,633 | +133.3% | 7,992 | -2.5% | 0.00% | – |
| Q4 2022 | $311,480 | +39.1% | 8,199 | +11.2% | 0.00% | – |
| Q2 2022 | $224,000 | -80.9% | 7,371 | -36.6% | 0.00% | -100.0% |
| Q3 2021 | $1,170,000 | -27.5% | 11,622 | +1.9% | 0.00% | 0.0% |
| Q2 2021 | $1,613,000 | +79.4% | 11,401 | +26.5% | 0.00% | 0.0% |
| Q1 2021 | $899,000 | -16.4% | 9,015 | +3.5% | 0.00% | 0.0% |
| Q4 2020 | $1,076,000 | +26.7% | 8,709 | -0.1% | 0.00% | 0.0% |
| Q3 2020 | $849,000 | -60.9% | 8,714 | -37.5% | 0.00% | -50.0% |
| Q2 2020 | $2,174,000 | +42.5% | 13,935 | +31.8% | 0.00% | 0.0% |
| Q1 2020 | $1,526,000 | -16.1% | 10,575 | +18.8% | 0.00% | 0.0% |
| Q4 2019 | $1,819,000 | +169.1% | 8,900 | +5.7% | 0.00% | +100.0% |
| Q3 2019 | $676,000 | -13.2% | 8,424 | +2.0% | 0.00% | 0.0% |
| Q2 2019 | $779,000 | +24.4% | 8,256 | +12.8% | 0.00% | 0.0% |
| Q1 2019 | $626,000 | +149.4% | 7,319 | +138.5% | 0.00% | – |
| Q3 2018 | $251,000 | – | 3,069 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 2,896,901 | $291,457,000 | 32.14% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 46,646 | $4,693,000 | 5.31% |
| Ikarian Capital, LLC | 471,400 | $47,423,000 | 3.34% |
| Duquesne Family Office | 695,033 | $69,927,000 | 2.27% |
| Camber Capital Management LP | 685,000 | $68,918,000 | 2.12% |
| LBJ Family Wealth Advisors, Ltd. | 30,359 | $3,054,000 | 1.82% |
| MADDEN SECURITIES Corp | 33,127 | $3,333,000 | 1.80% |
| Biondo Investment Advisors, LLC | 104,120 | $10,475,000 | 1.80% |
| Tolleson Wealth Management, Inc. | 60,750 | $6,112,000 | 1.73% |
| Keel Point, LLC | 97,074 | $9,767,000 | 1.26% |